Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6790b39f5037d966855b3484", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Venlafaxine Hydrochloride Extended Release Capsules IP 150mg", "description": "VELAXFINE XR 150 is a trusted pharmaceutical formulation containing Venlafaxine Hydrochloride Extended Release Capsules IP 150mg, designed to manage and alleviate symptoms of major depressive disorders, anxiety, and panic disorders. By maintaining a steady release of the active ingredient, this extended-release formulation provides long-lasting relief, promoting emotional stability and mental well-being throughout the day.\n\n \n\nKey Benefits:\n \nEffective Management of Depression: Helps reduce symptoms such as low mood, fatigue, and loss of interest in daily activities.\nAnxiety and Panic Relief: Alleviates anxiety and panic attacks, promoting calmness and emotional control.\nImproved Sleep Patterns: Supports better sleep quality by reducing symptoms of stress and overthinking.\nLong-Lasting Effect: The extended-release formula ensures steady medication levels for all-day relief.\nEnhanced Emotional Resilience: Boosts energy and concentration, helping patients regain control of their daily lives.\n \n\nHow Does It Work?\n \nVELAXFINE XR 150 functions as a dual-action antidepressant, targeting both serotonin and norepinephrine neurotransmitters. By inhibiting their reuptake in the brain, the medication increases the availability of these mood-regulating chemicals, improving communication between nerve cells. This mechanism helps combat depressive and anxiety symptoms, fostering mental clarity and stability.\n\n \n\nDirections for Use:\n \nDosage: Take one capsule daily or as prescribed by your healthcare provider.\nTiming: Preferably take the capsule at the same time each day to maintain consistent drug levels.\nConsumption: Swallow the capsule whole with water. Do not crush or chew, as this may affect the extended-release mechanism.\nFood: It can be taken with or without food, depending on your doctor's recommendation.\nNote: Always follow the prescribed dosage and consult your healthcare provider for adjustments based on your medical condition.\n\n \n\nSide Effects:\n \nWhile VELAXFINE XR 150 is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects: Nausea, dry mouth, dizziness, drowsiness, or sweating.\nRare Side Effects: Increased heart rate, blurred vision, or difficulty sleeping.\nSevere Reactions: Mood changes, unusual bleeding, or allergic reactions (rash, itching, or swelling).\nIf you experience persistent or severe side effects, seek medical attention promptly.", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "prescribed dosage", "capsule daily", "experience persistent", "unusual bleeding", "generally welltolerated", "velaxfine xr 150", "adjustments based", "healthcare provider", "stability directions", "nerve cells", "medication increases", "norepinephrine neurotransmitters", "reducing symptoms", "sleep quality", "mental wellbeing", "active ingredient", "steady release", "panic disorders", "alleviate symptoms", "daily lives", "food depending", "extendedrelease formulation", "extendedrelease mechanism food", "daily activities anxiety", "trusted pharmaceutical formulation", "doctors recommendation note", "dualaction antidepressant targeting", "overthinking longlasting effect", "low mood fatigue" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2031, "imageuri": "https://productimages.withfloats.com/actual/6790b410ab0e1c3d34a21310.png", "tileimageuri": "https://productimages.withfloats.com/tile/6790b410ab0e1c3d34a21310.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-22T09:00:15.61Z", "updatedon": "2025-01-22T09:02:07.236Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/venlafaxine-hydrochloride-extended-release-capsules-ip-150mg/2031", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 150 ", "category": "neurology", "tags": [ "Venlafaxine Prolonged Release Capsules IP 37.5 mg", "is 150 mg of venlafaxine: a high dose", "Venlafaxine hydrochloride extended-release capsules 75 mg", "Is venlafaxine a narcotic", "venlafaxine 150mg modified-release capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c10e66641561b0446977f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393", "price": 58.0, "discountamount": 17.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "day", "GAD", "food", "life", "SNRI", "mood", "75mg", "need", "EMAIL", "water", "brain", "lives", "225mg", "37.5mg", "levels", "adults", "option", "control", "ability", "evening", "morning", "response", "patients", "Benefits", "sweating", "24 hours", "adherence", "intervals", "increments", "medication", "depression", "Venlafaxine", "information", "restlessness", "palpitations", "sterispharma", "sterisonline", "Introduction", "Key Features", "CALL/WHATSAPP", "starting dose", "panic disorder", "Initial Dosage", "patient safety", "steady release", "Anxiety Relief", "excessive worry", "dosage strength", "Improved Quality", "physical symptoms", "treatment regimen", "Regular monitoring", "Dosage adjustments", "Maintenance Dosage", "therapeutic efficacy", "Continued Monitoring", "multiple daily doses", "long-term management", "Antidepressant Action", "overall effectiveness", "usual maintenance dose", "potential side effects", "social anxiety disorder", "favorable safety profile", "VELAXFINE XR 37.5 therapy", "various anxiety disorders", "consistent symptom relief", "major depressive disorder", "VELAXFINE XR 37.5 capsules", "gastrointestinal discomfort", "Administration Instructions", "Extended-Release Formulation", "generalized anxiety disorder", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1910, "imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:44:06.065Z", "updatedon": "2024-06-27T07:29:09.447Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 37.5 ", "category": "NEUROLOGY RANGE", "tags": [ "venlafaxine 37.5 mg", "VELAXFINE XR 37.5", "", "VELAXFINE XR 37.5 side effects", "venlafaxine 37.5mg used for", "venlafaxine urinary side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c060caebebd090016591c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMOTROP NPX ", "description": "SUMOTROP NPX \nSumatriptan (85mg), Naproxen (500mg)\nIntroduction:\n\nSUMOTROP NPX combines Sumatriptan and Naproxen to offer powerful, dual-action relief for acute migraine attacks. Sumatriptan, a selective serotonin receptor agonist, and Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), work together to alleviate migraine symptoms quickly and effectively, helping patients regain control of their lives.\nKey Features and Benefits:\n\nDual-Action Relief:\n\nSumatriptan (85mg): Targets serotonin (5-HT1) receptors to constrict dilated blood vessels in the brain, reducing headache pain and associated symptoms like nausea and sensitivity to light and sound.\nNaproxen (500mg): Reduces inflammation and pain through its action as an NSAID, providing additional relief and prolonging the effect of Sumatriptan.\nRapid and Long-Lasting Relief:\n\nThe combination of Sumatriptan and Naproxen ensures rapid onset of action, relieving migraine symptoms quickly. The anti-inflammatory properties of Naproxen also help maintain pain relief for a longer duration.\nComprehensive Symptom Management:\n\nSUMOTROP NPX addresses multiple migraine symptoms, including headache pain, nausea, and sensitivity to light and sound, providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy effectively managing migraine attacks, SUMOTROP NPX enables patients to resume their daily activities with minimal disruption, enhancing overall quality of life.\nWell-Tolerated and Safe:\n\nThis combination medication is generally well-tolerated, offering a favorable safety profile for patients needing acute migraine treatment.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMOTROP NPX is one tablet containing Sumatriptan (85mg) and Naproxen (500mg) taken orally at the first sign of a migraine attack.\nMaximum Dosage:\n\nDo not exceed two tablets in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow the tablet whole with water. Taking the medication with food may help reduce gastrointestinal side effects associated with Naproxen.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumotrop-npx-133632", "price": 104.95, "discountamount": 31.48, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "85mg", "food", "Life", "Order", "lives", "EMAIL", "NSAID", "light", "sound", "water", "brain", "500mg", "nausea", "control", "product", "therapy", "severity", "response", "patients", "Naproxen", "Benefits", "first dose", "first sign", "one tablet", "rapid onset", "sensitivity", "two tablets", "information", "Sumatriptan", "second dose", "pain relief", "inflammation", "Introduction", "sterispharma", "SUMOTROP NPX", "sterisonline", "Key Features", "headache pain", "CALL/WHATSAPP", "Maximum Dosage", "Initial Dosage", "initial relief", "24-hour period", "patient safety", "longer duration", "overall quality", "Improved Quality", "daily activities", "additional relief", "migraine frequency", "Regular monitoring", "minimal disruption", "associated symptoms", "Long-Lasting Relief", "Continued Monitoring", "dilated blood vessels", "acute migraine attacks", "combination medication", "favorable safety profile", "acute migraine treatment", "multiple migraine symptoms", "Administration Instructions", "serotonin (5-HT1) receptors", "anti-inflammatory properties", "powerful, dual-action relief", "comprehensive symptom relief", "gastrointestinal side effects", "Comprehensive Symptom Management", "nonsteroidal anti-inflammatory drug", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1901, "imageuri": "https://productimages.withfloats.com/actual/666c060f492d7ea0aba1c9f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c060f492d7ea0aba1c9f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:57:48.703Z", "updatedon": "2024-06-29T12:24:01.982Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumotrop-npx-/1901", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMOTROP NPX ", "category": "NEUROLOGY RANGE", "tags": [ "sumatriptan injection buy", "Naproxen (500mg)", "Sumatriptan (85mg)", "Sumatriptan (85mg),", "sumotrop npx uses in hindi", "sumotrop npx price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c03124cb45413344ec7be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMATROPH 50 ", "description": "SUMATROPH 50 \nSumatriptan succinate Rapid- Release (50mg)\nIntroduction:\n\nSUMATROPH 50 contains Sumatriptan succinate, a selective serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. With a dosage strength of 50mg in a rapid-release formulation, SUMATROPH 50 offers quick and effective relief from the debilitating symptoms of migraines, helping patients regain control over their daily lives.\nKey Features and Benefits:\n\nRapid-Release Formulation:\n\nSUMATROPH 50 is designed to provide rapid relief from migraine symptoms. Its quick absorption and onset of action help alleviate headache pain, nausea, and sensitivity to light and sound within a short period.\nTargeted Action:\n\nSumatriptan succinate specifically targets serotonin (5-HT1) receptors in the brain, leading to the constriction of dilated blood vessels, which is believed to be a primary cause of migraine pain. This targeted action effectively reduces the intensity and duration of migraine attacks.\nSymptom Relief:\n\nSUMATROPH 50 not only alleviates headache pain but also helps relieve associated migraine symptoms such as nausea, vomiting, and photophobia (sensitivity to light) or phonophobia (sensitivity to sound), providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy providing quick and effective relief from migraines, SUMATROPH 50 enables patients to resume their daily activities with minimal disruption, enhancing their overall quality of life.\nWell-Tolerated and Safe:\n\nSumatriptan is generally well-tolerated, with a favorable safety profile, making SUMATROPH 50 a reliable option for the acute treatment of migraines.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMATROPH 50 for adults is 50mg taken orally at the first sign of a migraine attack. The dose may be increased to 100mg if needed, based on individual response and tolerability.\nMaximum Dosage:\n\nDo not exceed 200mg in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow SUMATROPH 50 tablets whole with water. The rapid-release formulation ensures quick absorption and onset of action.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumatroph-50-133683", "price": 148.4, "discountamount": 44.52, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Life", "50mg", "light", "100mg", "onset", "sound", "brain", "200mg", "Order", "water", "EMAIL", "adults", "nausea", "option", "therapy", "control", "duration", "severity", "patients", "vomiting", "Benefits", "intensity", "migraines", "first sign", "first dose", "sensitivity", "second dose", "photophobia", "daily lives", "phonophobia", "information", "constriction", "Introduction", "sterisonline", "tolerability", "Key Features", "short period", "rapid relief", "sterispharma", "primary cause", "headache pain", "CALL/WHATSAPP", "migraine pain", "patient safety", "24-hour period", "Initial Dosage", "Maximum Dosage", "initial relief", "acute treatment", "dosage strength", "Targeted Action", "overall quality", "effective relief", "quick absorption", "Improved Quality", "daily activities", "migraine attacks", "minimal disruption", "Regular monitoring", "migraine frequency", "individual response", "Continued Monitoring", "debilitating symptoms", "dilated blood vessels", "favorable safety profile", "rapid-release formulation", "serotonin (5-HT1) receptors", "Administration Instructions", "Swallow SUMATROPH 50 tablets", "associated migraine symptoms", "comprehensive symptom relief", "Sumatriptan succinate Rapid- Release", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1900, "imageuri": "https://productimages.withfloats.com/actual/666c03182d43284d72746dc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c03182d43284d72746dc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:45:06.277Z", "updatedon": "2024-06-29T12:24:49.64Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumatroph-50-/1900", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMATROPH 50 ", "category": "NEUROLOGY RANGE", "tags": [ "SUMATROPH 50", "", "sumatriptan 50 mg tablet uses", "Sumatriptan succinate Rapid- Release (50mg)", "sumatriptan side effects", "sumatriptan 50 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6639c7719a37321adc599b66", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAROXTIME CR 25", "description": "PAROXTIME CR 25\nParoxetine 25 mg\nPAROXTIME CR 25, featuring 25 mg of Paroxetine, is a trusted medication designed to alleviate symptoms of various psychological conditions. This controlled-release formula ensures a steady effect throughout the day, enhancing your ability to manage depression, anxiety, and panic disorders effectively. By stabilizing mood and reducing anxiety, PAROXTIME CR 25 helps patients regain control over their daily lives. It's essential to consult with a healthcare provider to tailor the treatment to your specific needs and monitor for any side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n \n\n\n", "price": 195.0, "discountamount": 59.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "mood", "anxiety", "ability", "symptoms", "patients", "treatment", "depression", "Paroxetine", "daily lives", "side effects", "PAROXTIME CR", "steady effect", "specific needs", "panic disorders", "trusted medication", "healthcare provider", "controlled-release formula", "various psychological conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1147, "imageuri": "https://productimages.withfloats.com/actual/667d328f000f6c164f0952a5.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d328f000f6c164f0952a5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-07T06:17:21.294Z", "updatedon": "2024-06-27T09:36:12.846Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paroxtime-cr-25/1147", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Paroxetine 25 mg", "category": "NEUROLOGYRANGE", "tags": [ "Paroxetine 25 mg uses", "Paroxetine side effects sexually", "Paroxetine 25 mg price", "Paroxetine 25 मिलीग्राम", "Paroxetine 25 मिलीग्राम", "Paroxetine side effects", "Paroxetine 25 mg side effects", "", "Paroxetine 12.5 मिलीग्राम" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb577cb617ef27c577d94", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 50 DS", "description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.", "price": 100.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2178, "imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:52:39.162Z", "updatedon": "2025-09-08T10:52:39.162Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-50-ds/2178", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "cefpodoxime proxetil oral suspension ip 50 mg", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
regain control?

Still searching for
regain control?

Chat with us